Xeris Biopharma Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	111.04	71.62	67.45	121.97	67.27
Short-Term Investments	-	-	5	-	35.16
Cash & Short-Term Investments	111.04	71.62	72.45	121.97	102.43
Cash Growth	55.04%	-1.15%	-40.60%	19.07%	-23.44%
Accounts Receivable	51.05	40.42	39.2	30.83	17.46
Inventory	68.67	48.18	38.84	24.74	18.12
Other Current Assets	9.55	7.45	5.78	9.29	4.59
Total Current Assets	240.31	167.66	156.26	186.82	142.6
Net Property, Plant & Equipment	27.06	28.21	29.18	9.51	6.63
Other Intangible Assets	88.08	98.92	109.76	120.61	131.45
Goodwill	22.86	22.86	22.86	22.86	22.86
Other Long-Term Assets	5.22	5.41	4.54	4.73	0.83
Total Assets	383.53	323.06	322.6	344.52	304.36
Accounts Payable	3.08	2.29	11.57	4.61	8.92
Accrued Expenses	95.38	75.88	36.35	64.78	68.13
Current Portion of Long-Term Debt	-	15.1	-	-	-
Current Portion of Leases	6.23	6.08	3.5	1.58	-
Other Current Liabilities	4.89	1.09	20.28	2.66	1.99
Total Current Liabilities	109.57	100.44	95.19	73.62	79.04
Long-Term Debt	220.34	217.01	190.93	187.08	88.07
Long-Term Leases	31.53	33.26	34.76	9.4	-
Other Long-Term Liabilities	8.4	1.97	8.5	29.24	42.02
Total Long-Term Liabilities	260.26	252.23	234.19	225.71	130.09
Total Liabilities	369.84	352.68	329.38	299.34	209.13
Common Stock	0.02	0.02	0.01	0.01	0.01
Additional Paid-in Capital	685	642.26	610.25	599.97	555.36
Accumulated Other Comprehensive Income	-0.03	-0.03	-0.03	-0.02	-0.03
Retained Earnings	-671.31	-671.86	-617.03	-554.77	-460.11
Shareholders' Equity	13.69	-29.62	-6.78	45.19	95.23
Total Liabilities & Equity	383.53	323.06	322.6	344.52	304.36
Total Debt	258.1	271.45	229.19	198.06	88.07
Net Cash (Debt)	-147.06	-199.83	-156.74	-76.09	14.37
Net Cash Growth	-	-	-	-	-69.28%
Net Cash Per Share	-0.85	-1.36	-1.14	-0.56	0.18
Book Value	13.69	-29.62	-6.78	45.19	95.23
Book Value Per Share	0.08	-0.20	-0.05	0.33	1.21
Tangible Book Value	-97.25	-151.4	-139.41	-98.28	-59.08
Tangible Book Value Per Share	-0.56	-1.03	-1.01	-0.72	-0.75

Updated Mar 2, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q